Timken Company (The) Common Stock (TKR)

Total Non-Current Liabilities

$2.54B

Quarterly · Period ending: · USD

TKR logo

TKR Total Non-Current Liabilities

Latest reported$2.54B
TKR Quarterly Total Non-Current Liabilities ($304.40M → $2.54B)
High-resolution chart · PNG

TKR total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Timken Company (The) Common Stock Total Non-Current Liabilities — Quarterly (USD)
Period endingTotal Non-Current Liabilities (USD)
2,544,200,000
2,556,700,000
2,409,000,000
2,625,899,999
2,671,399,999
2,649,700,000
2,606,400,000
2,766,399,999
2,685,100,000
2,366,300,000
2,368,000,000
2,143,699,999
2,578,900,000
2,476,700,000
2,407,100,000
1,894,100,000
2,232,800,000
2,237,300,000
1,896,400,000
1,923,199,999
1,941,600,000
1,939,300,000
1,968,400,000
2,069,699,999
2,268,600,000
2,309,899,999
2,168,500,000
2,043,200,000
2,194,300,000
2,291,200,000
2,116,900,000
2,202,500,000
1,264,500,000
1,304,400,000
1,255,800,000
1,339,000,000
1,281,000,000
962,400,000
999,599,999
1,002,500,000
960,200,000
1,031,900,000
935,400,000
989,400,000
922,500,000
884,800,000
878,500,000
900,700,000
611,200,000
821,400,000
860,600,000
847,400,000
1,115,600,000
1,165,600,000
1,330,200,000
1,074,800,000
1,261,900,000
1,358,800,000
1,465,000,000
1,052,600,000
1,212,900,000
1,371,100,000
1,518,700,000
1,739,500,000
1,756,000,000
1,757,637,000
1,870,892,000
1,978,192,000
1,815,233,000
1,822,686,000
2,097,440,000
1,445,522,000
1,483,617,000
1,654,435,000
1,514,146,000
1,634,749,000
1,669,070,000
1,716,264,000
1,719,784,000
1,362,011,000
1,344,607,000
1,413,688,000
1,422,192,000
1,416,949,000
1,555,246,000
1,595,980,000
1,627,325,000
1,594,074,000
1,555,487,000
1,509,137,000
1,545,606,000
1,784,889,000
1,964,309,000
2,049,594,000
1,505,200,000
1,055,993,000
1,093,814,000
1,099,602,000
1,110,193,000
886,437,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.